Comparison of the effects of aminoguanidine and Nω-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat

European Journal of Pharmacology

Volumn 300, Issue 1-2, 1996, Pages 99-104

  Wu, Chin Chen ^a,b   Ruetten, Hartmut ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Endotoxin; Lipopolysaccharide; Liver failure; Multiple organ dysfunction syndrome; Nitric oxide (NO) synthase, inducible

Indexed keywords

AMINOGUANIDINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG SELECTIVITY; ENDOTOXEMIA; ENZYME INDUCTION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LIVER FAILURE; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; ENZYME INHIBITORS; ESCHERICHIA COLI; GUANIDINES; HYPOTENSION; KIDNEY; LIVER; MALE; MULTIPLE ORGAN FAILURE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR;

EID: 0029986709     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00877-2     Document Type: Article

References (17)

1. Corbett, J.A., R.G. Tilton, K. Chang, K.S. Hasan, Y. Ido, J.L. Wang, M.A. Sweetland, J.R. Lancaster, J.R. Williamson and M.L. McDaniel, 1992. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction, Diabetes 41, 552.
2. Griffiths, M.J.D., M. Messent, R.J. MacAllister and T.W. Evans, 1993, Aminoguanidine selectively inhibits inducible nitric oxide synthase, Br. J. Pharmacol. 110, 963.
3. G-methylarginine, Biochem. Biophys. Res. Commun. 170, 96.
4. Harbrecht, B.G., T.R. Billiar, J. Stadler, A.J. Demetris, J. Ochoa, R.D. Curran and R.L. Simmons, 1992, Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and oxygen-derived radical.-mediated hepatic injury, J. Leukocyte Biol. 52, 390.
5. Hasan, K., B.J. Heesen, J.A. Corbett, M.L. McDaniel, K. Chang, W. Allison, B.H.R. Wolffenbuttel, J.R. Williamson and R.G. Tilton, 1993. Inhibition of nitric oxide formation by guanidines, Eur. J. Pharmacol. 249, 101.
6. Hewett, J.A. and R.A. Roth, 1995, The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from Gram-negative bacteria, J. Pharmacol. Exp. Ther. 272, 53.
7. Hutcheson, I.R., B.J.R. Whittle and N.K. Boughton-Smith, 1990, Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat, Br. J. Pharmacol. 101, 815.
8. Kroncke, K.D., H.H. Brenner, M.L. Rodrguez, K. Etzkorn, E.A. Noack, H. Kolb and V. Kolb-Bachofen, 1993, Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitroc oxide, Biochim. Biophys. Acta 1182, 221.
9. Misko, T.P., W.M. Moore, T.P. Kasten, G.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. McDaniel, J.R. Williamson and M.G. Currie, 1993, Selective inhibition of the inducible nitric oxide synthase by aminoguanidine, Eur. J. Pharmacol. 233, 119.
10. Mitchell, J.A., K.L. Kohlhaas, R. Sorrentino, T.D. Warner, F. Murad and J.R. Vane, 1993, Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors, Br. J. Pharmacol. 109, 265.
11. Moncada, S. and A. Higgs, 1993, The L-arginine-nitric oxide pathway, New Engl. J. Med. 329, 2002.
12. Petros, A., D. Bennett and P. Vallance, 1991, Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock, Lancet 338, 1557.
13. Shultz, P.J. and L. Raij, 1992, Endogenously synthetized nitric oxide prevents endotoxin-induced glomerular thrombosis, J. Clin. Invest. 90, 1718.
14. Thiemermann, C., 1994, The role of the L-arginine-nitric oxide pathway in circulatory shock, Adv. Pharmacol. 28, 45.
15. Tilton, R.G., K. Chang, K.S. Hasan, S.R. Smith, J.M. Petrash, T.P. Misko, M.W. Moore, M.G. Currie, J.A. Corbett, M.L. McDaniel and J.R. Williamson, 1993, Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycosylation end-product formation, Diabetes 42, 221.
16. Wright, C.E., D.D. Rees and S. Moncada, 1992, Protective and pathological role of nitric oxide in endotoxin shock, Cardiovasc. Res. 26, 48.
17. Wu, C.C., S.J. Chen, C. Szabo, C. Thiemermann and J.R. Vane, 1995, Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock, Br. J. Pharmacol. 114, 1666.